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Five different types of protein kinase acivities have been evaluated in cell lines from murine lymphomas 
induced by Abelson leukemia virus (A-MuLV), whose oncogene codes for a tyrosine protein kinase. Such 
activities were compared with those of normal cells and of cells transformed by Moloney leukamia virus 
(M-MuLV), lacking oncogene sequences in its genome. While CAMP-dependent protein kinase and casein 
kinase-1 do not undergo significant changes, casein kinase-2 rises in both A-MuLV and M-MuLV infected 
lymphocytes, becoming largely associated with the particulate fraction of transformed cells. Protein kinase- 
C on the other hand is unchanged in M-MuLV transformed cells but it undergoes a 2-3-fold increment 
in both soluble and particulate fractions of A-MuLV transformed lymphocytes, which also display high 
tyrosine protein kinase activity. 
Abelson leukemia virus Maloney leukemia virus Protein kinase C Casein kinase 2 
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1. INTRODUCTION 
Protein phosphorylation catalyzed by protein 
kinases and reversed by protein phosphatases has 
been implicated in the regulation of many cellular 
processes (reviewed in [1,2]). Expectedly such a 
network of protein phosphorylations will be af- 
fected by that multitude of changes occurring dur- 
ing transformations, so that the identification of 
protein kinases undergoing marked alterations of 
activity could either shed some light on the 
mechanism of oncogenesis or provide helpful 
diagnostic tools. This would be especially true of 
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cells transformed by viruses coding for tyrosine 
protein kinases in which an increment of protein 
phosphorylation at seryl and not only tyrosyl 
residues has been reported to occur [3,4]. This 
observation which is suggestive of cascade 
mechanisms leading to the activation of cellular 
Ser/Thr specific protein kinases, prompted us to 
undertake a scrutiny of protein kinase activities in 
a murine cell line established from thymic lym- 
phomas induced by A-MuLV, whose oncogene ex- 
presses a tyrosine protein kinase [5,6]. Such 
activities were compared with those of normal 
murine lymphocytes and of a murine T cell lym- 
phoma line induced by M-MuLV, a slow transfor- 
ming retrovirus from which A-MuLV is derived, 
lacking however oncogene sequences coding for 
protein kinases. 
2. MATERIALS AND METHODS 
The transformed cells used in this study were: 
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TA-2, a non-B lymphoma cell line established 
from thymic lymphomas induced by inoculating 
intrathymically newborn BALB/c mice with the 
complex A-MuLV (M-MuLV); ABC-l, a A-MuLV 
transformed line of pre-B cells, kindly provided by 
Dr N. Teich [7]; TB-5, a T-cell lymphoma line in- 
duced by M-MuLV in BALB/c mice. Controls in- 
cluded normal thymus and spleen cells isolated 
from BALB/c mice or stimulated in vitro with con- 
canavalin A or LPS, respectively. Cells were 
cultured in complete medium as described 
elsewhere [8]. 
Cells were disrupted and fractionated essentially 
as in [9] giving rise to a clear cytosol and a par- 
ticulate fraction. The particulate fraction was par- 
tially solubilized at pH 7.5 with non-ionic 
detergents, essentially as in [lo] except for the 
substitution of Triton X-100 with 1% NP40. Pro- 
tein kinase assays were carried out on both cytosol 
and NP40 extract. 
Tyrosine protein kinase activity was routinely 
determined on poly(Glu, Tyr) 4: 1 (Sigma) as 
substrate, as in [lo]. Casein kinase activity was 
assayed on whole casein as in [l 11, either in the 
absence or presence of 10 pg/ml heparin, in order 
to discriminate between type-l (heparin insen- 
sitive) and type-2 (heparin inhibited). Protein 
kinase-C was evaluated as the Ca’+, 
phosphatidylserine-dependent phosphorylation of 
the synthetic peptide Orn$-Tyr-Gly-Ser-Om-Tyr, 
at its single seryl residue, under the conditions 
described in [12]. In some experiments the peptide 
substrate was replaced by protamine and Ca2+ and 
phospholipid were omitted. CAMP-dependent pro- 
tein kinase was determined toward the synthetic 
peptide Arg-Arg-Ala-Ser-Val-Ala, as in [ 131. One 
unit of protein kinase activity was constantly 
defined as the amount of enzyme transferring 
1 pmol P per min to the peptide or protein 
substrate under standard conditions. 
A partial resolution of protein kinase activities 
was achieved by subjecting the NP40 extracts of 
particulate fractions to DEAE-Sepharose column 
chromatography. The columns (1.5 x 4 cm) were 
equilibrated with 25 mM Hepes buffer, pH 7.0, in- 
cluding also 10% glycerol, 1 mM EDTA, 0.1% 
NP40, 10 mM mercaptoethanol and 50 PM PMSF. 
Elution was performed with a O-O.5 M NaCl 
linear gradient in the same buffer. 0.9 ml fractions 
were collected and assayed for their PK-C (Ca2+, 
60 
phospholipid stimulated), protamine kinase and 
casein kinase activities. 
3. RESULTS AND DISCUSSION 
The specific activities of several protein kinases 
in normal and transformed thymocytes are 
reported in fig.1. Fig.lA refers to the cytosolic 
fraction and shows that while CAMP-dependent 
protein kinase and casein kinase-1 (heparin insen- 
sitive) are virtually unchanged in tumoral cells, ca- 
sein kinase-2 (heparin inhibited) is increased in 
both M-MuLV and A-MuLV transformed cells. 
Such an increment is not evident in thymocytes 
which have been stimulated to proliferate with 
concanavalin A (netted bars). Unlike CK-2, Cat+, 
phospholipid-dependent protein kinase-C is almost 
unchanged in M-MuLV transformed cells while it 
undergoes a remarkable increment in the cytosolic 
fraction of A-MuLV transformed thymocytes. The 
same is true of tyrosine protein kinase activity 
whose appearance in A-MuLV transformed cells is 
seemingly attributable, at least in part, to the 
kinase expressed by the v-abl-oncogene. 
A parallel scrutiny of the NP40 extract of the 
particulate fraction (fig. 1B) discloses a situation 
similar to that of the cytosol: in this case however 
Fig. 1. Evaluation of CAMP-dependent protein kinase 
(CA-PK), protein kinase-C (PK-C), tyrosine protein 
kinase, casein kinase-1 (CK-1) and casein kinase-2 
(CK-2) in the cytosol (A) and NP40 extractable 
particulate fraction (B) of normal thymocytes (open 
bars) and of cell lines transformed by either Moloney 
(hatched bars) or Abelson leukemia viruses (filled bars). 
Netted bars, where shown, refer to the activity of 
thymocytes timulated with concanavalin A. The results 
of a typical experiment are reported. Very similar values 
were obtained with 6 different preparations (variations 
of specific activities never exceeded 10%). 
Volume 206, number 1 FEBS LETTERS September 1986 
a direct evaluation of Ca’+, phospholipid- 
dependent activity resulted impossible, probably 
due to the presence of detergent, and PK-C was 
evidenced using protamine, a rather specific 
substrate whose phosphorylation does not require 
addition of activators [14]. By such an approach 
protamine kinase activity, as well as tyrosine pro- 
tein kinase activity, were found substantially in- 
creased only in the membranes of cells acutely 
transformed by A-MuLV. On the other hand, ca- 
sein kinase-2, almost absent in the particulate frac- 
tion of normal cells either quiescent or activated by 
concanavalin-A, reaches notable levels in the mem- 
branes of cells infected with either M-MuLV or A- 
MuLV. CAMP-dependent protein kinase and CK-1 
do not undergo any remarkable variations. The 
reproducibility of these data has been checked by 
comparing normal and transformed cells of six dif- 
ferent preparations: the increments of CK-2, PK-C 
and tyrosine protein kinase outlined in fig.1 were 
constantly observed in all preparations. 
To make sure that the heparin inhibited casein 
kinase activity detected in the membranes of 
transformed cells is actually due to casein kinase-2, 
its chromatographic behaviour on DEAE- 
Sepharose and its responsiveness to specific effec- 
tors were checked: most of the casein kinase activi- 
ty exhibited retarded elution from DEAE- 
Sepharose, as expected for CK-2 (fig.ZA). Further- 
more by all the criteria listed in table 1 (stimulation 
by polylysine and spermine, inhibition by 
polyglutamate, capability of utilizing GTP) such a 
retarded casein kinase peak was attributable to 
CK-2 rather than to CK-1 or to other forms of ca- 
sein kinase. 
On the other hand, the increased protamine 
kinase activity of A-MuLV transformed cell mem- 
branes was almost entirely due to PK-C as also 
proven by DEAE-Sepharose chromatography 
(fig.2B) showing that over 80% of it is eluted as a 
Ca’+, phospholipid-dependent peak, while the re- 
maining activity is more retarded, as expected for 
the spontaneously active proteolytic derivative of 
PK-C (PK-M). 
A very similar increment of PK-C has also been 
observed in a cell line obtained by transforming 
with A-MuLV pre-B lymphocytes, rather than 
thymocytes (fig.3): also in this case such an incre- 
ment is accompanied by the appearance of 
cytosolic tyrosine protein kinase and by an increase 
of CK-2, whereas CAMP-dependent protein kinase 
and CK-1 are not significantly altered. 
In conclusion our data disclose a remarkable in- 
crement of PK-C activity in both soluble and par- 
ticulate fractions of lymphoid cells which have 
been transformed by Abelson leukemia virus 
whose oncogene codes for a tyrosine protein 
kinase. This observation is especially important in 
the light of previous reports showing that A-MuLV 
infection also induces increased Ser/Thr protein 
phosphorylation in the transformed cells, affecting 
in particular the ribosomal protein S6 [15], whose 
50 100 
FRACTIONS 
Fig.2. Resolution by DEAE-Sepharose gradient 
chromatography of casein kinase (A) and protein kinase- 
C (B) activities extracted with NP40 from the particulate 
fraction of TA-2 cells transformed by Abelson leukemia 
virus. (M) Casein kinase; (W) protamine kinase; 
(M) and (O---O) activities toward the synthetic 
peptide Orti-Tyr-Gly-Ser-Om-Tyr in the presence and 
absence of Ca*+ (5OO/cM) and phosphatidylserine 
(50 rg/ml), respectively. 
61 
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Table 1 
Influence of various effecters on casein kinase-2 isolated 
from the particulate fraction of TA-2 cells transformed 
by Abelson leukemia virus 
Additions Casein kinase activity 
None 100 
Heparin (10 pg/ml) 17 
Polyglutamic acid (0.2 mg/ml) 43 
Unlabeled GTP (100 ,uM) 46 
Polylysine (0.2 mg/ml) 420 
Spermine (0.4 mM) 344 
Extraction of casein kinase activity and DEAE- 
Sepharose column chromatography were performed as 
described in section 2. The fractions of the more 
retarded predominant peak (see also fig.ZA) were pooled 
and casein kinase activity assayed in the presence of 
various effecters. Activities are expressed as percent of 
control 
susceptibility to PK-C has recently been 
demonstrated [ 16,171. Considering that no ap- 
preciable increment of PK-C activity could be 
observed in cells transformed by M-MuLV, whose 
genome lacks any oncogene coding for tyrosine 
protein kinase, it is tempting to speculate that the 
rise of PK-C in A-MuLV transformed cells is 
directly or indirectly triggered by the tyrosine pro- 
tein kinase expressed by v-abl-oncogene, through a 
cascade mechanism. 
On the other hand, a different mechanism must 
be responsible for the high CK-2 activity which is 
observed in transformed lymphocytes infected by 
either A-MuLV or M-MuLV as opposed to quies- 
Fig.3. Evaluation of different protein kinase activities in 
the cytosol of B-lymphocytes (open bars) and of a pre-B 
cell line transformed by Abelson leukemia virus (filled 
bars). Symbols are the same as in fig.1. B-lymphocytes 
were obtained by stimulating mouse spleen cells 
suspension with LPS. The results are the mean of 4 
experiments (variations never exceeded 8%). 
cent and proliferating normal cells. Seemingly such 
a rise in CK-2 activity is a common feature of 
transformed cells and appears to be in good agree- 
ment with a previous report indicating a rise of 
CK-2 as a general property of cell lines which have 
undergone immortalization [ 181. Our additional 
finding that such an increment of CK-2 in lym- 
phoid cells is largely accounted for by the de novo 
appearance of a membrane bound form of this en- 
zyme provides a new hint for insight into the possi- 
ble relationships between alterations of CK-2 and 
carcinogenesis . 
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